Why is the Bubs (ASX:BUB) share price leaping 7% on Tuesday?

Let's further analyse.

| More on:
Two young girls drinking milkshakes with milk around their mouths.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price is set to finish today's session strongly in the green.

Investors have bid shares in the goat milk infant formula company 7% higher.

By comparison, the broader S&P/ASX200 Index (ASX: XJO) has sunk more than 1.4% today.

So what's been fuelling the Bubs share price?

What's pushing the Bubs share price today?

Bubs has not released any price-sensitive news that could explain today's bullish price action.

As a result, there are a few factors that could be pushing shares in the infant formula company higher.

Firstly, shares in fellow infant formula producer A2 Milk Company Ltd (ASX: A2M) have enjoyed a strong run recently.

As a result, sentiment towards the sector could be parlayed onto the Bubs share price.

Secondly, investors might have had a change in heart towards Bub's recent news of expanding into the US.

Earlier this month the company announced plans to expand into the lucrative North American market.

The company's formula products will be launched on both Walmart Inc's (NYSE: WMT) and Amazon.com, Inc.'s (NASDAQ: AMZN) online stores.

Investors did not react to the news favourably, with the Bub share price sinking more than 9% on the day.

The company had flagged first shipment of products in its results presentation for FY21.  

How did Bub's perform in FY21?

Late last month, shares in Bubs took a tumble following a disappointing full-year report.

The infant formula company posted a huge loss for FY21, with a 24% decline in revenue of $46.8 million.

The dour result was driven by a 44% decline in Australian sales to $20.4 million and a 17.5% decline in China sales to $10.47 million.

Other highlights from the company's full-year report included;

  • Underlying EBITDA loss of $28.5 million
  • Statutory loss after tax of $74.7 million
  • Cash balance of $27.9 million

Part of the company's loss for the full year was attributed to a $44.6 million non-cash impairment relating to the Nulac Foods cash generating unit.

Bubs noted that weaker sales, a $12.6 million inventory write down, and the sale of excess bulk powder attributed to a bloated operating loss.

Snapshot of the Bubs share price

Today has provided a brief reprieve for Bub's shareholders.

Shares in the infant formula company have not had a great year, trading more than 39% lower since the start of 2021.

At the time of writing, the Bubs share price is poised to close today's session more than 5% higher.

The company's shares were up more than 11% earlier, having hit an intra-day high of 38 cents.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Motley Fool contributor Nikhil Gangaram owns shares of A2 Milk. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Amazon. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. The Motley Fool Australia has recommended A2 Milk, Amazon, and BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »